Friday, 2 March 2018

Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta

(Reuters) - Biogen Inc and AbbVie Inc have withdrawn their multiple sclerosis drug worldwide due to safety issues, the companies said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)